It's in clinical trial right now with result due next year, the R&D cost for development and pre-clinical trial has been already done.....
Ann: AVR host TAVR KOL Symposium moderated by Credit Suisse, page-25
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.70 |
Change
0.190(1.41%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $13.83 | $13.35 | $123.6K | 9.057K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.81 | 150 | 1 |
View Market Depth
| Last trade - 11.24am 09/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |